Financings In Brief
This article was originally published in The Gray Sheet
Small Bone Innovations raises $108 million to launch STAR ankle: Orthopedic firm raises $108 million in a "Series D" private placement of preferred stock to help support the ongoing U.S. launch of its STAR total ankle replacement system. STAR became the first motion-preserving, mobile-bearing ankle replacement device available in the United States following PMA approval May 27 (1"The Gray Sheet" June 1, 2009). Announced June 30, the "Series D" financing closed in April; it follows a $36 million "Series C" funding round in 2008. Aside from supporting the STAR launch, proceeds from the offerings helped to complete the 2008 acquisition of the STAR technology from German firm Waldemar Link, as well as to retire a $20 million credit facility, according to the company
You may also be interested in...
Small Bone Innovations (SBi) hopes its STAR total ankle replacement system will be the catalyst for a shift in ankle procedures away from the fusion surgery standard toward a market dominated by joint replacement. But the barriers in the still-limited ankle replacement space are not trivial
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.